Atlas Trials

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

Clinical trial NCT05063643 · UNKNOWN

Trial details

NCT number
NCT05063643
Sponsor
Affiliated Hospital of Qinghai University
Status
UNKNOWN
Study type
OBSERVATIONAL
HER2-positive Breast CancerTargeted TherapyCardiac ToxicityHigh Altitude
Start date
2021-10-01
Primary completion
2024-12-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.